Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Eyepoint Pharms drug DEXYCU KIT appeared f…
New patent expiration for Eyepoint Pharms drug DEXYCU KIT Read Post »
Annual Drug Patent Expirations for LEVITRA Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug and three Paragraph…
The post New patent expiration for Bayer Hlthcare drug LEVITRA appeared …
New patent expiration for Bayer Hlthcare drug LEVITRA Read Post »
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Currax drug ONZETRA XSAIL appeare…
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
Annual Drug Patent Expirations for DOPTELET Doptelet is a drug marketed by Akarx Inc and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Akarx Inc drug DOPTELET appeared first on Dr…
New patent expiration for Akarx Inc drug DOPTELET Read Post »
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-five patents protecting…
The post New patent expiration for NOVO drug OZEMPIC appeared first …
Annual Drug Patent Expirations for FERAHEME Feraheme is a drug marketed by Covis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for COVIS drug FERAHEME appeared first on Dru…
Annual Drug Patent Expirations for KENGREAL Kengreal is a drug marketed by Chiesi and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Chiesi drug KENGREAL appeared first …
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared fir…
New patent expiration for Oncopeptides Ab drug PEPAXTO Read Post »